IFN-κ is critical for normal wound repair and is decreased in diabetic wounds
Authors:
- Sonya J. WolfSWSonya J. Wolf
- Christopher O. AuduCAChristopher O. Audu
- Amrita JoshiAJAmrita Joshi
- William J. MelvinWMWilliam J. Melvin
- Frank M. DavisFDFrank M. Davis
- Xianying XingXXXianying Xing
- Rachael WasikowskiRWRachael Wasikowski
- Johann E. GudjonssonJGJohann E. Gudjonsson
- Mary X. O’RIordanMOMary X. O’RIordan
Open Access
- 9 May 2022
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (9)
Abstract
Wound repair following acute injury requires a coordinated inflammatory response. Type I IFN signaling is important for regulating the inflammatory response after skin injury. IFN-κ, a type I IFN, has recently been found to drive skin inflammation in lupus and psoriasis; however, the role of IFN-κ in the context of normal or dysregulated wound healing is unclear. Here, we show that Ifnk expression is upregulated in keratinocytes early after injury and is essential for normal tissue repair. Under diabetic conditions, IFN-κ was decreased in wound keratinocytes, and early inflammation was impaired. Furthermore, we found that the histone methyltransferase mixed-lineage leukemia 1 (MLL1) is upregulated early following injury and regulates Ifnk expression in diabetic wound keratinocytes via an H3K4me3-mediated mechanism. Using a series of in vivo studies with a geneticall y engineered mouse model ( Mll1 fl/fl K14 cre– ) and human wound tissues from patients with T2D, we demonstrate that MLL1 controls wound keratinocyte–mediated Ifnk expression and that Mll1 expression is decreased in T2D keratinocytes. Importantly, we found the administration of IFN-κ early following injury improves diabetic tissue repair through increasing early inflammation, collagen deposition, and reepithelialization. These findings have significant implications for understanding the complex role type I IFNs play in keratinocytes in normal and diabetic wound healing. Additionally, they suggest that IFN may be a viable therapeutic target to improve diabetic wound repair.Keywords
Funding Information
- National Institutes of Health (R01-HL137919)
- National Institutes of Health (R01-DK124290)
- National Institutes of Health (R01 HL15627401)
- National Institutes of Health (R01 DK127531)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01-AR071384)
- Penn Skin Biology and Diseases Resource-based Center, University of Pennsylvania (1P30-AR075043)
- Michigan Nutrition Obesity Research Center, Medical School, University of Michigan (P30-DK089503)
This publication has 48 references indexed in Scilit:
- Epigenetic regulation of the alternatively activated macrophage phenotypeBlood, 2009
- The Role of Vascular Endothelial Growth Factor in Wound HealingJournal of Surgical Research, 2009
- Alternative Activation of Macrophages: An Immunologic Functional PerspectiveAnnual Review of Immunology, 2009
- Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-κB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexesOncogene, 2009
- Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetesBritish Journal of Dermatology, 2008
- Macrophage activation and polarizationFrontiers in Bioscience-Landmark, 2008
- Analysis of IFN- κ Expression in Pathologic Skin Conditions: Downregulation in Psoriasis and Atopic DermatitisJournal of Interferon & Cytokine Research, 2006
- Interferon-κ, a Novel Type I Interferon Expressed in Human KeratinocytesJournal of Biological Chemistry, 2001
- The Expression and Modulation of IFN-α and IFN-β in Human KeratinocytesJournal of Interferon & Cytokine Research, 1997
- Identification and expression cloning of a leptin receptor, OB-RCell, 1995